Aethlon Medical Inc.

  • TickerAEMD
  • ISINUS00808Y2081
  • CountryUnited States

FDA IDE Approval of Human Cancer Study is Major Milestone (and clearly underappreciated by the Street)

ValuEngine Rating and Forecast Report for AEMD

ValuEngine Rating and Forecast Report for AEMD

ValuEngine Rating and Forecast Report for AEMD

ValuEngine Rating and Forecast Report for AEMD

ValuEngine Rating and Forecast Report for AEMD

ValuEngine Rating and Forecast Report for AEMD

ValuEngine Rating and Forecast Report for AEMD

ValuEngine Rating and Forecast Report for AEMD

FDA IDE Approval of Human Cancer Study is Major Milestone (and clearly underappreciated by the Street)

AEMD: SeaStar Collaboration Is Intriguing, More Evidence of Exosomes Role in Cancer Progression

AEMD: Eventual FDA Cancer Indication Is A Realistic Outcome

AEMD: Breakthrough Device Designation Granted for Cancer Therapy. Could Be Game-Changer for AEMD

AEMD: Pivot Towards Cancer Makes Sense. FDA Filing For Breakthrough Device in Cancer

ValuEngine Rating and Forecast Report for AEMD

ValuEngine Rating and Forecast Report for AEMD

ValuEngine Rating and Forecast Report for AEMD

ValuEngine Rating and Forecast Report for AEMD

ValuEngine Rating and Forecast Report for AEMD

ValuEngine Rating and Forecast Report for AEMD

ValuEngine Rating and Forecast Report for AEMD

ValuEngine Rating and Forecast Report for AEMD

ValuEngine Rating and Forecast Report for AEMD

ValuEngine Rating and Forecast Report for AEMD

ResearchPool Subscriptions

Get the most out of your insights

Get in touch